Pemetrexed Maintenance Therapy Following Bevacizumab-Containing First-Line Chemotherapy in Advanced Malignant Pleural Mesothelioma: A Case Report and Literatures Review

Malignant pleural mesothelioma (MPM) is a lethal disease with poor prognosis. The combination of cisplatin and pemetrexed has been confirmed as the standard of care for nonoperable MPM. Data have shown that the adoption of pemetrexed maintenance therapy (PMT) following first-line treatment appears e...

Descripción completa

Detalles Bibliográficos
Autores principales: Jing, Xu-Quan, Zhou, Lei, Sun, Xin-Dong, Yu, Jin-Ming, Meng, Xue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998834/
https://www.ncbi.nlm.nih.gov/pubmed/27057918
http://dx.doi.org/10.1097/MD.0000000000003351

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998834/
https://www.ncbi.nlm.nih.gov/pubmed/27057918
http://dx.doi.org/10.1097/MD.0000000000003351

Ejemplares similares